Page last updated: 2024-11-04

sulforaphane and Uterine Cervical Neoplasms

sulforaphane has been researched along with Uterine Cervical Neoplasms in 3 studies

sulforaphane: from Cardaria draba L.
sulforaphane : An isothiocyanate having a 4-(methylsulfinyl)butyl group attached to the nitrogen.

Uterine Cervical Neoplasms: Tumors or cancer of the UTERINE CERVIX.

Research Excerpts

ExcerptRelevanceReference
"Sulforaphane (SFN) is a natural, compound-based drug derived from dietary isothiocyanates which has previously been shown to possess potent anti-tumor and chemopreventive effects against several types of cancer."1.43Sulforaphane, a Dietary Isothiocyanate, Induces G₂/M Arrest in Cervical Cancer Cells through CyclinB1 Downregulation and GADD45β/CDC2 Association. ( Cheng, YM; Hsu, YC; Tsai, CC, 2016)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cheng, YM1
Tsai, CC1
Hsu, YC1
Sharma, C2
Sadrieh, L2
Priyani, A2
Ahmed, M2
Hassan, AH1
Hussain, A2
Brahmbhatt, K1

Other Studies

3 other studies available for sulforaphane and Uterine Cervical Neoplasms

ArticleYear
Sulforaphane, a Dietary Isothiocyanate, Induces G₂/M Arrest in Cervical Cancer Cells through CyclinB1 Downregulation and GADD45β/CDC2 Association.
    International journal of molecular sciences, 2016, Sep-12, Volume: 17, Issue:9

    Topics: Anticarcinogenic Agents; Antigens, Differentiation; CDC2 Protein Kinase; Cell Line, Tumor; Cell Prol

2016
Anti-carcinogenic effects of sulforaphane in association with its apoptosis-inducing and anti-inflammatory properties in human cervical cancer cells.
    Cancer epidemiology, 2011, Volume: 35, Issue:3

    Topics: Anticarcinogenic Agents; Antimetabolites, Antineoplastic; Apoptosis; Cell Survival; Cyclooxygenase 2

2011
Concurrent sulforaphane and eugenol induces differential effects on human cervical cancer cells.
    Integrative cancer therapies, 2012, Volume: 11, Issue:2

    Topics: Anticarcinogenic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Proliferati

2012